|

IDE892 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • IDEAYA Biosciences1

Indications

  • Squamous Cell Car. - Esophagus1
  • Adenocarcinoma of Esophagus1
  • Urothelial Carcinoma (UC)1
  • Gastroesophageal Cancer (GC)1
  • NSCLC Adenocarcinoma1

Houston, Texas1 trial

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NEXT Oncology Houston

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.